Sign in

CIK 0001528115

  • Non-accelerated filer
  • Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275414423
Phone
+1 650-822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,106 shares at $6.02 ($6,658)
  2. 4 Open-market buy Director bought 3,200 shares at $5.00 ($16,000)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy Director bought 3,200 shares at $4.83 ($15,459)
  10. 4 Open-market buy Director bought 3,200 shares at $4.68 ($14,982)
  11. 4 Open-market buy Director bought 3,200 shares at $6.07 ($19,411)
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award CHIEF MEDICAL OFFICER acquired 39,000 shares (grant or award)
  14. 4 Grant or award EVP & CHIEF SCIENTIFIC OFFICER acquired 39,000 shares (grant or award)
  15. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 2,593 shares at $5.53 ($14,339)
  16. 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 2,604 shares at $5.51 ($14,348)
  17. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 1,951 shares at $5.48 ($10,691)
  18. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 1,349 shares at $5.53 ($7,460)
  19. 4 Open-market sale PRESIDENT AND CEO sold 5,782 shares at $5.54 ($32,032)
  20. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,809 shares at $5.54 ($10,022)

Page 5 of 11 · 206 filings